Folgen
Laura E. Happe
Laura E. Happe
Director of Online MS Program, Associate Professor, University of Florida
Bestätigte E-Mail-Adresse bei ufl.edu
Titel
Zitiert von
Zitiert von
Jahr
Graphical depiction of longitudinal study designs in health care databases
S Schneeweiss, JA Rassen, JS Brown, KJ Rothman, L Happe, P Arlett, ...
Annals of internal medicine 170 (6), 398-406, 2019
1822019
Use of combination vaccines is associated with improved coverage rates
GS Marshall, LE Happe, OE Lunacsek, MD Szymanski, CR Woods, ...
The Pediatric infectious disease journal 26 (6), 496-500, 2007
1702007
Leveraging health-related quality of life in population health management: the case for healthy days
SL Slabaugh, M Shah, M Zack, L Happe, T Cordier, E Havens, ...
Population health management 20 (1), 13-22, 2017
1002017
Outcomes of a digital health program with human coaching for diabetes risk reduction in a Medicare population
CM Castro Sweet, V Chiguluri, R Gumpina, P Abbott, EN Madero, ...
Journal of aging and health 30 (5), 692-710, 2018
932018
A systematic literature review assessing the directional impact of managed care formulary restrictions on medication adherence, clinical outcomes, economic outcomes, and health …
LE Happe, D Clark, E Holliday, T Young
Journal of Managed Care Pharmacy 20 (7), 677-684, 2014
922014
Combination vaccine use and vaccination quality in a managed care population
LE Happe, OE Lunacsek, GS Marshall, T Lewis, S Spencer
American Journal of Managed Care 13 (9), 506-513, 2007
562007
Approaches to the management of agents used for the treatment of multiple sclerosis: consensus statements from a panel of US managed care pharmacists and physicians
RM Miller, LE Happe, KL Meyer, RJ Spear
Journal of Managed Care Pharmacy 18 (1), 54-62, 2012
502012
Impact of a pentavalent combination vaccine on immunization timeliness in a state Medicaid population
LE Happe, OE Lunacsek, DT Kruzikas, GS Marshall
The Pediatric infectious disease journal 28 (2), 98-101, 2009
482009
Venous thromboembolism after orthopedic surgery: implications of the choice for prophylaxis
AF Shorr, LM Kwong, M Sarnes, L Happe, E Farrelly, N Mody-Patel
Thrombosis research 121 (1), 17-24, 2007
482007
Burden of deep vein thrombosis in the outpatient setting following major orthopedic surgery
EA Nutescu, AF Shorr, E Farrelly, R Horblyuk, LE Happe, M Franklin
Annals of Pharmacotherapy 42 (9), 1216-1221, 2008
312008
Comparative evaluation of patients newly initiating first-generation versus second-generation tyrosine kinase inhibitors for chronic myeloid leukemia and medication adherence …
MA Ward, G Fang, KL Richards, CM Walko, SR Earnshaw, LE Happe, ...
Current Medical Research and Opinion 31 (2), 289-297, 2015
272015
Missed opportunities for human papillomavirus vaccine initiation in an insured adolescent female population
CM Espinosa, GS Marshall, CR Woods, Q Ma, D Ems, I Nsiah, LE Happe, ...
Journal of the Pediatric Infectious Diseases Society 6 (4), 360-365, 2017
242017
Consequences of major bleeding in hospitalized patients with non-ST segment elevation acute coronary syndromes receiving injectable anticoagulants
LE Happe, SV Rao, R Horblyuk, M Franklin, OE Lunacsek, L Menditto
Current medical research and opinion 25 (2), 413-420, 2009
222009
Comparison of cost, effectiveness, and safety of injectable anticoagulants used for thromboprophylaxis after orthopedic surgery
AF Shorr, MW Sarnes, PJ Peeples, RH Stanford, LE Happe, E Farrelly
American Journal of Health-System Pharmacy 64 (22), 2349-2355, 2007
192007
Distinguishing predatory from reputable publishing practices
LE Happe
Journal of managed care & specialty pharmacy 26 (8), 956-960, 2020
152020
Cost and occurrence of thrombocytopenia in patients receiving venous thromboembolism prophylaxis following major orthopaedic surgeries
LE Happe, EM Farrelly, RH Stanford, MW Sarnes
Journal of thrombosis and thrombolysis 26, 125-131, 2008
152008
Do case rates affect physicians' clinical practice in radiation oncology?: An observational study
BA Loy, CI Shkedy, AC Powell, LE Happe, JA Royalty, MT Miao, GL Smith, ...
PLoS One 11 (2), e0149449, 2016
132016
Incidence of nonmelanoma skin cancer in the United States population aged 65 years and older, 2014
H Rogers, M Beveridge, J Puente, S Wixson, B Loy, LE Happe
Journal of the American Academy of Dermatology 85 (3), 741-743, 2021
112021
Alternative payment models in medical oncology: assessing quality-of-care outcomes under partial capitation
D Ems, S Murty, B Loy, J Gallagher, LE Happe, TL Rogstad, D Finnel, ...
American health & drug benefits 11 (7), 371, 2018
102018
Choosing the best treatment for multiple sclerosis: comparative effectiveness, safety, and other factors involved in disease-modifying therapy choice
LE Happe
Am J Manag Care 19 (Suppl 17), S332-S342, 2013
102013
Das System kann den Vorgang jetzt nicht ausführen. Versuchen Sie es später erneut.
Artikel 1–20